Sanuwave is a medical device company that develops and commercializes UltraMIST, an FDA-cleared, noninvasive ultrasound system for treating acute and chronic wounds in hospitals, clinics, nursing facilities, and other healthcare settings. The company generates revenue through a razor-and-blade model, selling UltraMIST systems to healthcare providers and recurring revenue from sterile, single-use applicator consumables that account for the majority of revenue. Sanuwave competes in the large U.S. wound care market by emphasizing its technology's non-contact application, ease of use, patient tolerability, and support for evidence-based wound care and decentralized treatment delivery.